Curcumin clinical research
In recent years, curcumin has become a “popular guest” in the global health nutritional raw material industry. Whether in scientific research, bioavailability improvement, new products launch or other respects, curcumin is undoubtedly a hot spot in the market. According to the research from Credence, which is a market research company, the global market for curcumin will continue to grow steadily during the forecast period, with the market value of curcumin estimated to be as high as $84 million by 2022.
Curcumin is the principal curcuminoid of turmeric (Curcuma longa), a member of the ginger family, it is an important herb in the Ayurveda system in India with more than 5,000 years history. Curcumin can be used to treat a variety of common diseases, such as skin, lungs, gastrointestinal system diseases, pain, wounds, liver damage, joint pain and inflammation. Curcumin has a variety of health effects mainly because of its superior antioxidant properties and anti-inflammatory properties.
In the past 30 years, there have been more than 8,000 scientific studies on curcumin, and curcumin has changed from the role of kitchen spices to herbal supplements. Curcumin is known to have powerful antioxidant and anti-inflammatory properties that can relieve a variety of diseases such as metabolism, cardiovascular disease, cancer, arthritis, and Alzheimer’s disease. The following are the representative literature on curcumin clinical studies, let’s see the newest progresses on curcumin clinical research
Curcumin clinical research
- Cancer
Breast cancer is a common form of fatal cancer. In a non-randomized, non-blind clinical trial, 25 patients with advanced breast cancer received curcumin treatment for up to 8 weeks without any form of chemotherapy. The results showed that taking curcumin products daily for 8 weeks, could reduce the reduction of inflammatory marker factors in most patients, such as NF-KB and COX-2, and the tumor size of some patients was also reduced by 73 %.
- Metabolic syndrome
In a randomized, double-blind, placebo-controlled, parallel trial, taking of curcumin for 8 weeks significantly reduced serum triglycerides, total cholesterol, serum LDL cholesterol, non-HDL cholesterol and lipoprotein, compared to the placebo subjects . At the same time, another randomized, double-blind, placebo-controlled clinical trial was done , 118 diabetic patients received 10 mg-1,000 mg of curcumin or placebo per day, and the results of the study showed that curcumin is an effective antioxidant has an effect in alleviating type 2 diabetes and complications.
- Cognitive health
A randomized, double-blind, placebo controlled trial showed that patients with mild to moderate Alzheimer’s had a daily intake of 2-4 g curcumin for 24 consecutive weeks, the results showed good tolerance and efficacy.
- Bone arthritis
New research shows that daily taking 1500 mg of curcumin products in patients with knee osteoarthritis significantly reduced pain, body function, and stiffness, while the number of participants in the curcumin group who took naproxen decreased by 84 %.
- Peptic ulcers and related symptoms
Patients with peptic ulcers take 500 mg of curcumin products daily and then receive standard Helicobacter pylori treatment, the results show that the symptoms of peptic ulcers have significantly improved without any side effects.
Turmeric is not only a star in the pharmaceutical industry, but also has important significance in the spice industry. Turmeric is not only one of the important raw materials in curry, but also used by ancient Indians as sweeteners, dyes, and food additives (antiseptics). The rapid increase in the market for curcumin is also related to the growing demand for herbal and Ayurveda skin care products. Curcumin clinical research continues in the future!
